Share Capital (Details) - USD ($) $ in Thousands |
4 Months Ended | 12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Feb. 17, 2021 |
Sep. 06, 2019 |
Sep. 03, 2019 |
Sep. 10, 2018 |
Apr. 30, 2021 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Feb. 14, 2020 |
Aug. 30, 2019 |
|
| Share Capital (Details) [Line Items] | ||||||||||
| Pre-paid warrant to purchase | 811,085 | |||||||||
| Ordinary shares | 811,085 | |||||||||
| Exercised warrants | 992,149 | |||||||||
| Return amount (in Dollars) | $ 3,969 | |||||||||
| Restricted shares | 12,000 | |||||||||
| Issue of ordinary shares | 12,000 | |||||||||
| Stock option, description | The total issuance costs accumulated to $3,200. | |||||||||
| Shares return value (in Dollars) | $ 1,700 | $ 1,800 | ||||||||
| Shares issued | 445,000 | |||||||||
| Aggregate purchase price (in Dollars) | $ 4,450 | |||||||||
| Fair value of options granted (in Dollars) | 3,970 | $ 1,094 | $ 2,952 | |||||||
| Employee Benefits and Share-Based Compensation (in Dollars) | $ 2,637 | |||||||||
| Weighted average period | 1 year 9 months 18 days | |||||||||
| Warrant [Member] | ||||||||||
| Share Capital (Details) [Line Items] | ||||||||||
| Exercised warrants | 992,149 | |||||||||
| Exercised shares | 425,000 | 450,000 | ||||||||
| Ordinary Shares [Member] | ||||||||||
| Share Capital (Details) [Line Items] | ||||||||||
| Exercised shares | 425,000 | 450,000 | ||||||||
| Convertible Loan Agreement [Member] | ||||||||||
| Share Capital (Details) [Line Items] | ||||||||||
| Principal amount (in Dollars) | $ 6,500 | |||||||||
| Sagy Purchase Agreement [Member] | ||||||||||
| Share Capital (Details) [Line Items] | ||||||||||
| Stock option, description | On the first closing date, which occurred on September 3, 2019, Ami Sagy transferred to the Company the principal amount of $2,000. This amount was invested on account of the issuance in a form of convertible loan and was automatically converted into 500,000 ADSs at a conversion price of $4.00 per ADS on October 27, 2019. On the second closing date, which occurred on February 28, 2021, after the Company executed the Development, Exclusivity and Option Products Agreement (see note 8), the following occurred: (i) Ami Sagy transferred the Company an amount of $1,000 by way of an equity investment, and (ii) the Company issued to Ami Sagy 250,000 ADSs representing 250,000 ordinary shares and a warrants to purchase up to 250,000 ADSs representing 250,000 ordinary shares. On the third closing date, which was subject to shareholder approval and occurred on October 27, 2019, the Company issued to Ami Sagy a warrant to purchase up to 500,000 ADSs representing 500,000 ordinary shares. The consideration of the third closing is included in the principal amount received in the first closing. | |||||||||
| U. S. Agreement [Member] | ||||||||||
| Share Capital (Details) [Line Items] | ||||||||||
| Stock option, description | On the second closing date, which occurred on October 27, 2019, the following occurred: (i) the principal amount invested on account of the issuance in a form of convertible loan, was automatically converted into 875,000 ADSs at a conversion price equal to $4.00 per ADS, and (ii) the Company issued to the U.S. Investors warrants to purchase up to 875,000 ADSs representing 875,000 ordinary shares. | |||||||||
| Meitav Dash Purchase Agreement [Member] | ||||||||||
| Share Capital (Details) [Line Items] | ||||||||||
| Warants exercise, description | On October 27, 2019, an extraordinary general meeting was held and the Company received the “shareholders’ approval” and subsequently issued the ADSs and warrants as mentioned above. The Company also issued an aggregate of 175,039 ADSs to Mr. Sagy, and Meitav Dash, and 250,000 ADSs and 20,000 prepaid warrant to purchase up to 20,000 ADSs to Alpha in satisfaction of the price protection undertakings under the Alpha Purchase Agreement, the Meitav Dash Purchase Agreement and the Sagy Purchase Agreement. In 2021, one of the U.S investors exercised 450,000 warrants into 450,000 ordinary shares ADS in return of $1,800. In 2022, three U.S investors exercised 425,000 warrants into 425,000 ordinary shares in return of $1,700. d) On February 14, 2020, the Company entered into a Securities Purchase Agreement with several accredited U.S. investors, pursuant to which the Company issued on March 6, 2020, in a private placement, 445,000 ordinary shares for an aggregate purchase price of $4,450. e) On February 17, 2021, the Company completed a registered direct offering providing for the sale and issuance of an aggregate of 2,000,000 ADSs at a purchase price of $17.50 per ADS, for aggregate gross proceeds of $35,000. The total issuance costs accumulated to $3,200. | |||||||||
| Two Tranches [Member] | ||||||||||
| Share Capital (Details) [Line Items] | ||||||||||
| Principal amount (in Dollars) | 3,000 | |||||||||
| One Tranche [Member] | ||||||||||
| Share Capital (Details) [Line Items] | ||||||||||
| Principal amount (in Dollars) | $ 3,500 | |||||||||
| Third Tranches [Member] | ||||||||||
| Share Capital (Details) [Line Items] | ||||||||||
| Restricted shares | 4,000 | |||||||||
| Issue of ordinary shares | 4,000 | |||||||||